Antibe Therapeutics Inc(Pre-Merger) ATBPF

RE:RE:RE:RE:Analysts are bullish on ATE

[MasterAlgae]

I've been wondering about that for a while now Straylight. It is a facinating subject.

It's not like the established firms will sell more of the NSAIDs - they already have the market. If it is X billion dollar market and you already own it - and bringing a new and improved product to market costs a billion then you have a billion less. So why do it? Not from the goodness of Big Pharma heart.

I do see an incentive for collusion.
What is the financial benefit to a manufacturer? I see only increased costs. If a manufacturer is already selling X, making X better wont mean more sales, its not like X is a recreation product. The Median Cost of Bringing a single Drug to Market is $985 Million.
https://www.biospace.com/article/median-cost-of-bringing-a-new-drug-to-market-985-million/

Never underestimate the power of collusion of established firms to keep an upstart or its product(s) out of the market. That might explain the sound of crickets we've been hearing for years. It might also underline the CEOs statement around smaller company partnership(s).

We all want to make easy money - but biotech investing is a hard way to make easy money....